Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1038-1044
Published online before print March 3, 2005, doi: 10.1161/01.ATV.0000161274.87407.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/5/1038    most recent
01.ATV.0000161274.87407.26v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizaka, N.
Right arrow Articles by Yamakado, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizaka, N.
Right arrow Articles by Yamakado, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1038.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals

Nobukazu Ishizaka; Yuko Ishizaka; Ei-Ichi Toda; Ryozo Nagai; Minoru Yamakado

From the Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine (N.I., R.N.), and Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital (Y.I., E-I.T., M.Y.), Tokyo, Japan.

Correspondence to Dr Nobukazu Ishizaka, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Hongo 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan. E-mail nobuishizka-tky{at}umin.ac.jp

Objective— There are few data available on possible independent association between uric acid and carotid atherosclerosis. Here we first sought to investigate association between uric acid levels and metabolic syndrome in Japanese; second, we assessed whether there is an independent association of uric acid with prevalence of carotid atherosclerosis in individuals subdivided according to gender and metabolic syndrome status.

Methods and Results— Cross-sectional data from 8144 individuals who underwent general health screening were analyzed. After adjusting for age, total cholesterol, and smoking status, the odds ratios (95% CI) of sex-specific quartiles of serum uric acid for metabolic syndrome were 1.0, 1.06 (0.60 to 1.87), 2.18 (1.30 to 3.64), and 4.17 (2.56 to 6.79) in women, and 1.0, 0.92 (0.74 to 1.14), 1.52 (1.25 to 1.65), and 1.97 (1.61 to 2.40) in men. After adjusting for age, serum levels, total cholesterol, and smoking status, prevalence of carotid plaque was higher in subjects in the second, third, and fourth quartiles of uric acid level with odds ratios (95% CI) of 1.24 (1.01 to 1.52), 1.37 (1.11 to 1.68), and 1.31 (1.05 to 1.63), respectively, in men without metabolic syndrome but not in men with metabolic syndrome or in women with or without metabolic syndrome.

Conclusion— The prevalence of metabolic syndrome showed a graded increase according to serum uric acid values in both genders. In men who did not have metabolic syndrome, uric acid was found to be an independent risk factor for incidence of carotid plaque.

Whether there is an independent association of uric acid with prevalence of carotid atherosclerosis was analyzed. Serum uric acid values are associated with carotid plaque independently of other atherogenic risk factors in men without but not with metabolic syndrome or in women at all.


Key Words: metabolic syndrome • carotid atherosclerosis • ultrasonography • insulin resistance • multivariate analysis




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I. P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, and R. J. Johnson
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F710 - F718.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K.-L. Chien, M.-F. Chen, H.-C. Hsu, W.-T. Chang, T.-C. Su, Y.-T. Lee, and F. B. Hu
Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
Clin. Chem., February 1, 2008; 54(2): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Ishizaka, Y. Ishizaka, E.-I. Toda, K. Koike, M. Yamakado, and R. Nagai
Are Serum Carcinoembryonic Antigen Levels Associated With Carotid Atherosclerosis in Japanese Men?
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 160 - 165.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. S. Ford, C. Li, S. Cook, and H. K. Choi
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
Circulation, May 15, 2007; 115(19): 2526 - 2532.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Ruggiero, A. Cherubini, A. Ble, A. J.G. Bos, M. Maggio, V. D. Dixit, F. Lauretani, S. Bandinelli, U. Senin, and L. Ferrucci
Uric acid and inflammatory markers
Eur. Heart J., May 2, 2006; 27(10): 1174 - 1181.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Zoccali, R. Maio, F. Mallamaci, G. Sesti, and F. Perticone
Uric Acid and Endothelial Dysfunction in Essential Hypertension
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1466 - 1471.
[Abstract] [Full Text] [PDF]